Trial intelligence / Profile preview

Restylane and Triamcinolone for Alopecia Areata

NCT01797432Phase 2Completed

Sponsor
University of Minnesota
Start
Mar 2009
Primary completion
Nov 2014
Modality
Injectable Hydrogels, Implantable Devices, Implantable Hydrogels
Countries
1
01

Overview

A Phase 2 trial of nasha hyaluronic acid in alopecia areata, sponsored by University of Minnesota. Started Mar 2009; status: completed.

02

Drugs

nasha hyaluronic acid
03

Conditions

alopecia areata

Beyond the preview

Go deeper on NCT01797432.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01797432.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call